Introduction: The epidemiological and social relevance of dementia and mild cognitive impairment increases with life expectancy and prevalence of metabolic disorders. The recognition of an important role for dietary nutrients on cognitive functioning opens new preventive strategies. This work analyses the association between erythrocyte omega-3 index and omega-6 / omega-3 ratio and cognitive performance/ mild cognitive impairment. Material and Methods: We selected a random sample of individuals registered at a health centre aged ≥ 55 years. Participants were asked about their alimentary habits, erythrocyte indexes were determined and neuropsychological evaluation included the Montreal Cognitive Assessment and a comprehensive test battery. Results: Mean age of 90 participants was 64 years (sd = 5.6), 71.1% had four years of education and 40% of them had more than one vascular risk factor. Limits for omega-3 index and omega-6 / omega-3 ratio were 2.90 -9.79 (mean = 6.20; sd = 1.50) and 1.14 -2.95 (mean = 2.12; sd = 0.39), respectively. Montreal Cognitive Assessment scores ranged from 10 to 29 (mean = 22; sd = 4.5), increasing on average 1 -2 points for above average omega-3 values and an omega-6 / omega-3 ratio ≤ 2 (Group 1) and decreasing 5 -6 points for omega-3 below mean values and the same omega-6 / omega-3 ratio (Group 2). Prevalence of mild cognitive impairment was 25.6% (95% CI: 16.4 -34.7), ranging from 12.5% to 83.3% in the two groups above. Discussion: This preliminary study is one of the first analyzing the repercussion of omega-3 index and omega-6 / omega-3 ratio on cognitive functioning, considering additionally the participant clinical and dietary profiles. Conclusion: The association found suggests that omega-3 and omega-6 / omega-3 ratio could be important biomarkers in the prevention of cognitive impairment. (3):213-223 ▪ https://doi.org/10.20344/amp.7970 RESUMO Introdução: A relevância epidemiológica e social da demência e do défice cognitivo ligeiro aumenta com a esperança de vida e prevalência das doenças metabólicas. O reconhecimento da importância dos nutrientes no funcionamento cognitivo perspectiva novas estratégias preventivas. Neste trabalho analisamos a associação entre os valores do índice ómega-3 e da razão ómega-6 / ómega-3 e desempenho cognitivo/ défice cognitivo ligeiro. Material e Métodos: Selecionamos uma amostra aleatória de utentes de um centro de saúde com idade ≥ 55 anos, que foram inquiridos sobre hábitos alimentares e sujeitos a avaliação neuropsicológica, incluindo o Montreal Cognitive Assessment, e determinando-se os índices indicados.
INTRODUCTION
Dementia and mild cognitive impairment (MCI) have assumed an increasing relevance due to ageing population and to high social, psychological and economic impact on patients, their families and society. Significant resources in dementia research have been aimed to the study of MCI over the past few years, to its differentiation from normal ageing as well as to MCI conversion to dementia. A 12-15% prevalence rate has been found in patients aged over 65, with a 10-15% annual conversion rate of amnestic MCI to Alzheimer's disease (AD), in contrast with low rates, not higher than 1-2%, in a population of normal individuals with the same age. 1-6 A 12.3% prevalence rate of MCI has been found in Portugal in people aged 55-79, in 2003-2004. 7 These numbers show the relevance of this concept and the need for regular monitoring of patients in this age group. Major benefits of a reduction of the prevalence of dementia will certainly relate to an early intervention, as patients with MCI are increasingly the target population in different clinical trials. Even though no therapy has so far showed any proved efficacy in preventing the progression from MCI to dementia, the effects of nutrition and the different nutrients in cognition has been one of the most promising lines of research. A certain protective role of Mediterranean-type dietary pattern -including the consumption of fish, vegetables, fresh fruit, olive oil and nuts, as well as the benefit of diet supplementation with B12 and B6 vitamin, folic acid, antioxidants and omega-3 (n-3) polyunsaturated fatty acids (PUFA) seem to exist. Omega-3 PUFA (DHA: docosahexaenoic acid and EPA: eicosapentaenoic acid), phosphatidylserine, folic acid, E and B12 vitamin and Gingko biloba are those having shown higher neuroprotective effects among the different agents studied. [8] [9] [10] [11] [12] [13] [14] Omega-3 index has been recognized as a relevant cardiovascular risk marker and has been recently studied as a possible marker of cognitive impairment. Therefore, an omega-3 index ≥ 8% is associated with higher cardiac protection, while an index ≤ 4% is associated with the risk of coronary heart disease 15 and omega-3 fatty acids have been recognized as essential nutrients aimed at the promotion of healthy ageing. 16 A comprehensive laboratorial study is usually included in clinical MCI evaluation even though the determination of the omega-3 index or the omega-6 / omega-3 ratio is not a current practice. However, recent studies showed an association between omega-6 / omega-3 ratio and dementia or cognitive impairment; cognitive impairment can be enhanced between 10 to 80% in patients with lower n-3 PUFA intake or increased consumption of omega-6 (n-6) PUFA. 17 A 1:1 n-6/n-3 ratio would be found in the ancestral human diet and has been increasing up to much higher values in the industrialized societies and levels of 15:1 or even 25:1 have been described in Western populations. DNA synthesis in the brain is very limited and, for that reason, the effects of the n-3 PUFA in cognition are expected to be higher with diets rich in DHA vs. those containing its precursors. 17, 18 For instance, some studies have shown lower values of n-3 index in patients with Alzheimer's disease when compared to healthy controls. 19, 20 A three-month dietary supplementation with DHA in animal models of AD 21 or a diet with low n-6 / n-3 ratio 22,23 led to the reduction of the n-6/n-3 ratio and the levels of Aβ and insoluble tau proteins in the brain, which are the major neuropathological markers of AD. In a recent study, the supplementation with DHA in a group of patients with cognitive impairment showed benefits at six months, when compared to placebo. 24 Benefits of an enriched diet with n-3 PUFA (vs. n-6 PUFA) were also shown regarding the progression of atherosclerotic risk markers (lipid profile, inflammatory cytokines, rheological parameters, homocysteine) or the stabilisation of carotid and coronary atherosclerotic plaques. [25] [26] [27] Different population studies, including the Portuguese population 7 have also shown that classical cardiovascular risk factors are also prominent risk markers for the development of dementia, even regarding non-vascular neurodegenerative forms (e.g. Alzheimer's disease), implying the presence of shared or synergic physiopathogenic mechanisms.
The results suggested that low dietary n-6 / n-3 ratio, obtained by higher consumption of n-3 PUFA or lower intake of n-6 PUFA can induce important beneficial effects in the maintenance of the cognitive function and the prevention of dementia. This study aimed at the analysis of the relationship between cognitive performance / MCI and blood levels of erythrocyte omega-3 index and omega-6 / omega 3 ratio, considering the clinical and nutritional profile of the participants.
MATERIAL AND METHODS Sample
A randomly selected group of patients attending the Community Health Centre (Centro de Saúde) at the municipality of Lousada has been involved in the study, based on the following criteria: active registration, even registration number and over 55 years of age. The patients with history of addiction to alcohol or other psychotropic drugs based on the analysis of the clinical records were excluded from the study ( Fig. 1 ). Patients were recruited by phone up to approximately 120 participants were obtained (this number has been considered as adequate for a multiple Final sample n = 90 regression analysis involving 10 predictor variables).
Procedure
Upon approval by the management of the health centre, the aims and procedures of the study were previously explained to each participant and/or carer and a written informed consent has been signed. Each participant has been evaluated as follows: a) Socio-demographic data, clinical history with comprehensive laboratorial tests and details on current drug and vitamin supplementation therapy collected during a semi-structured interview; b) Modified six-item, 0-21 range, AUDIT testing used for the determination of patient's alcohol consumption 28 ; c) Subjective Memory Complaints, 10-item, cut-off > 3, testing 29, 30 ; d) Montreal Cognitive Assessment (MoCA) testing; a cut-off value of 1 standard deviation below the mean according to patient's age and educational level (ages 55-64; ≥ 65 and 1 -4, 5 -9, 10 -12 and > 12 years of education) has been adopted for the definition of cognitive impairment. 31 44, 45 ; g) Hospital Anxiety and Depression Scale (HADS), normal -< 8; mild 8 -10; moderate > 10 46 ; h) Nutritional questionnaire based on the consumption frequency of fish (codfish, lean fish, fatty fish, preserved fish), meat (white, red, smoked), nuts (walnuts, almonds, hazelnuts), dairy products and vegetables, on a scale from 0 -never to 7 -daily. The cognitive assessment has been carried out by two neuropsychologists (C. P. and C. S.) at the health centre. Blood sampling has been collected for the determination of the omega-3 index and omega-6 /omega-3 ratio (10mL venous blood sample. Upon a resting period, plasma separation has been obtained by centrifugation at 700 x g (2500 rpm) for 10 min. Resulting plasma has been removed and the erythrocyte pellet has been washed with the same volume of saline (0.9% NaCl solution in water), followed by centrifugation at 700 x g for 5 min. The pellet was washed one more time and 0.5 mL has been collected into a labelled and stoppered tube which has been kept at -80ºC until further analysis. The erythrocytes have been used for the analysis of the phospholipid fatty acids according with the methodology described in a previous study. 47 The values of the index were dichotomized with the following criteria: the mean value of the sample has been used for the omega-3 index and a value of 2 has been considered as adequate for the determination of omega-6 / omega-3 ratio. 48
Statistical analysis
Analysis of variance (ANOVA) models and multiple comparisons using Scheffé's test, upon checking for assumptions of normality (Kolmogorov-Smirnov test) and assessing for the equality of variances (Levene's test) assuming a p-value >0.01 for checking for assumptions were used for the analysis of the relationship between the assessment of the cognitive performance (MoCA) and the variables defining the socio-demographic profile, cognitive functioning, comorbidities, medication and omega-3 index and omega-6 / omega-3 ratio; the presence of linear and/or quadratic mean trend regarding ordinal variables has been analysed. The relationship between food consumption, erythrocyte count and cognitive performance has been assessed using Pearson's correlation coefficient. The association between these variables and the prevalence of cognitive impairment in MoCA testing has been analysed with Pearson's chi-square test or Fisher's exact test regarding dichotomous variables; linear trend in proportions has been tested as regards the ordinal variables. These procedures were repeated for cognitive impairment within the different domains of MoCA testing.
Different models of multiple linear regression adjusted to patient's gender and age and to possible confounding variables (associated with performance, p <0.1) were used for the determination of the predictive value of omega-3 index and omega-6 / omega-3 ratio in cognitive performance; a first model has been adjusted to patient's cognitive functioning and social and demographic profile; a second one was also adjusted to comorbidities and to medication and the last model was also adjusted to food consumption. A value of p < 0.05 has been adopted as upper limit to wrongly reject the null hypothesis. IBM SPSS Statistics 21 software has been used in data analysis.
RESULTS

Profile of participants
A total of 21 patients out of the eligible 119 were excluded from the study, three of whom due to alcohol addiction. Upon the initial assessment, eight patients were additionally excluded, one having not completed the questionnaire and the remaining due to illiteracy having not been confirmed and MoCA testing having not been adequate for the diagnosis of cognitive impairment in this population (7.2% of the total). The remaining 90 participants were aged 55 to 82 (m = 64.0; sd = 5.6) and male participants (48.9%) had higher average age (65.7; sd = 6.0 vs. 62.4; sd = 4.8).
Most participants (71.1%) had four years of education, eight (8.8%) had nine and five (5.5%) had 14 or above, with similar values for both genders. Approximately 62% of the participants were pre-retired or retired and 22 (24.4%) were still active ( Table 1 ). The region of Lousada is predominantly industrial; 42 (46.7%) of the participants worked in industry and 25.6% were non-qualified workers or did not receive any remuneration, including 16 (34.8%) housewives. Almost all the participants lived with their family (93.3%), were still active (77.8%) and functionally independent for daily tasks (92.2%). High blood pressure was the most prevalent cardiovascular risk factor found (51.1%), followed by dyslipidaemia (44.4%), heart disease (26.7%) and diabetes (17.8%) (36 participants (40.0%) presented with more than one risk factor); neurological (10.0%) or cerebrovascular disorders (3.3%) were less prevalent ( Table  2 ). Approximately 32.2% of the participants had a history of depression, even though only 11.1% were currently on antidepressants and 31.1% on benzodiazepines.
Omega-3 index values ranging between 2.90 and 9.79 (mean = 6.20; sd = 1.50) and omega-6 / omega-3 ratio values between 1.14 and 2.95 (mean =2.12; sd = 0.39) have been found and the distribution is shown in Fig. 2 . A linear correlation between both indices has been found (r = -0.65; p < 0.001) and increasing to r = -0.82 when two of the extreme values were excluded from the combination (low levels in both indices). A brief presentation of the nutrition profile of the participants is shown in Table 3 , characterised by a high consumption (more than 4 times per week) of vegetables (81.1%), dairy products (56.7%) and white meat (51.1%) while fat fish (68.9%), lean fish (64.4%), codfish (55.6%), red meat (35.6%) and preserved fish (32.2%) were mostly consumed 2-3 times per week. In addition, smoked meat, nuts and cephalopod consumption were not included as these were not consumed by 36.7%, 35.6% and 34.4% of the participants, respectively. Omega-3 index and omega-6 / omega 3 ratio were both correlated with lean fish (r = 0.26 and r = -0.25, respectively) and cephalopod (r = 0.25 and r = -0.22, respectively) consumption frequency; nut consumption was also correlated with the omega-3 index (r = 0.24) and dairy product consumption with the omega-6 /omega-3 ratio (r = -0.26). Consumption frequency of the remaining food groups did not correlate with any of the indices (shown in Table 3 ).
Cognitive performance
Cognitive assessment using MoCA testing ranged between 10 and 29 (mean = 22.0; sd = 4.5) and followed a normal distribution (p > 0.22). The average levels were significantly different between patient's three levels of education (p < 0.05), regarding occupational sectors (staff / self-employed vs. non-qualified workers, p < 0.05) and cognitive functioning ( Table 1) . A linear trend between the MocA test score and patient's age (p < 0.02) and the level of anxiety (p < 0.1) has also been found. Overall, there is a lower cognitive performance in patients with comorbidities, even though significant differences were only found regarding the presence of a history of cerebrovascular or heart disorder and high blood pressure ( Table 2) . A lower cognitive performance has been found with less cardiovascular risk factors (p < 0.003), even though better results have been found in participants on anti-depressants or benzodiazepines.
A significant increase in cognitive performance has been found in patients showing high values of omega-3 index (p < 0.002) or low omega-6 / omega-3 ratio, even though a significant effect of the omega-3 index (F (1.86( = 7.5; p <0.008) and interaction (F (1.86) = 7.1; p < 0.009) has been found when a two-factor and interaction ANOVA model was considered, which was not found regarding the omega-6 / omega -3 ratio, showing that this significant increase regarded the subgroup with a low ratio and related to the contrast between high and low n-3 (Table 2) . Cephalopod, preserved fish and nut consumption was associated with cognitive performance; increased consumption frequency of these food groups is reflected on an improved cognitive performance ( Table 3) .
Regardless of the variables included in the regression model, the participants with a value of omega-3 above the mean and n-6 / n-3 ratio ≤ 2 scored 1-2 points above the remaining participants and those with a value of omega-3 below the mean and n-6 / n-3 ratio ≤ 2 scored on average 5-6 points below the remaining participants (Table 4 ). Education (p < 0.001), the number of vascular risk factors (p <0.02) and nut consumption frequency were other independent predictive factors of the cognitive performance. Depending on the number of factors included in the model, the inclusion of laboratorial variables led to a 45.6% (Model 1), 28.4% (Model 2) and 19.9% (Model 3) relative increase in R².
Cognitive impairment
A score below the reference level has been found in 23 Table 2 ). Even though a higher prevalence rate of cognitive impairment has been found in participants with low omega-3 index and high n-6 / n-3 ratio, significant differences were found in the group of patients with low n-6 / n-3 ratio, in whom a 83.3% prevalence has been found in patients with low omega-3 index vs. 12.5% in those with high omega-3 index values (Fig. 2) . The prevalence of cognitive impairment was not associated with food consumption frequency, even though it was tendentially lower in patients with higher fish (fat, lean, preserved, codfish) or even cephalopod consumption, unlike what happened in those with high meat consumption, particularly smoked meat ( Table 3) .
As regards the presence of cognitive impairment within the different domains of the MoCA testing, we found that it is more frequent in Language (46.7%), Memory (40.0%) and Abstraction (36.7%) ( Table 5 ). The values of omega-3 index and omega-6 / omega-3 ratio were associated with an impairment in Naming (p < 0.003) and in Memory (p < 0.002), which did not occur within the remaining domains.
As regards the results obtained with neuropsychological test battery and considering the cognitive impairment shown by the other neuropsychological tests, is was more frequent in Memory (74.4%), Language (25.6%) and Attention and Processing Speed (24.4%). Cognitive impairment in Attention and Processing Speed was associated with the values of both indices (p < 0.002) and tendentially with Executive Functions and Language. Lower impairment has been found in the group of participants with omega-3 index > 6.2 and n-6 / n-3 ratio ≤ 2, followed by the group with n-6 / n-3 ratio > 2 (regardless of the value of n-3) and values of omega-3 < 6.2 and n-6 / n-3 ratio ≤ 2 are indicative of higher impairment within the abovementioned domains (results not shown). 
DISCUSSION
We can come to the conclusion that there is a relationship between the values of n-3 and n-6 / n-3 ratio and cognitive performance in this group of patients aged over 55 and living in the municipality of Lousada; the group of patients with n-3 below the mean and n-6 / n-3 > 2 had a high risk of cognitive impairment while the group with n-3 values above the mean and n-6 / n-3 ≤ 2 was the most protected group from cognitive impairment. This has been assessed with MoCA testing and mostly regarded failures on Naming and Memory, while it was higher in Attention/Processing Speed and Executive Functions, as far as neuropsychological tests are concerned.
It would have been expected that cognitive performance and impairment would be focused in groups of patients with high n-6 / n-3 ratio, usually described as having a high risk of cognitive impairment. 49 However, the values of this ratio did not exceed 3.0 in this group of patients. The low variability (range: 1.14-2.95) found in this index may be explained by the essentially Mediterranean-type dietary pattern, with a frequent consumption of vegetables, meat from free-range animals and fish.
Dietary fat sources, even though more diversified in Europe than in the USA, have changed a lot over the past decades, with higher consumption of sunflower oil instead of olive oil, even in producing countries such as Portugal and Spain. 50 Considering the relationship between the values of both indices and cognitive impairment upon adjustment to possible confounding variables, approximately 10% variability is explained by the presence of these two groups of patients -lower MoCA scores in participants with simultaneously low n-3 and n-6 / n-3 ratio and higher MoCA scores in participants with n-3 above the mean and low n-6 / n-3 ratio.
The remaining variables with protective effect explaining for the cognitive performance included patient's education and nut consumption frequency; the protective effect of nuts regarded a moderate consumption when compared to the remaining patients (regression model with linear and quadratic term adjusted to the relationship described in Table 3 ). In addition, worse cognitive performance has been found in participants with higher number of cardiovascular risk factors. These have already been described in literature due to their association with cognitive performance. 7 Beydoun et al. have described an association between cognitive impairment assessed by a verbal fluency test and high levels of n-6 fatty acids, even in the absence of high n-6 / n-3 ratio. 51 The authors found an association between n-6 / n-3 ratio and cognitive impairment assessed by MMSE in a study involving 304 institutionalized elderly patients, as opposed to the consumption of fish and other marine products. 52 Other studies in humans and in animals emphasised that n-6 / n-3 ratio is associated with the risk of dementia and cognitive decline and lower consumption of n-3 is related to 10-80% increased cognitive decline. [19] [20] [21] [22] [23] [24] 
CONCLUSION
Even though the dimension of our group of patients does not allow for more definitive conclusions regarding the presence of cognitive impairment (23 out of 90 participants), this has been one of the first studies considering a wider range of population characteristics, based not only in the clinical information of patients attending the Portuguese Serviço Nacional da Saúde (an advantage related to the fact that a specific population has been available for random selection), but also including information on less common aspects such as food consumption, which has been relevant in the study of cognitive performance. Nunes All in all, cognitive performance and impairment were related to the values of erythrocyte omega-3 index and n-6 / n-3 ratio in a predominantly lower-literacy population (84.4% with ≤ 4 years of education) in whom 40% of the patients presented with at least two cardiovascular risk factors, with a characteristic Mediterranean dietary pattern, suggesting that these are important biomarkers for the prevention of cognitive decline.
The need for reinforcing n-3 fatty acid intake has also been shown, namely through the consumption of fish, algae and nuts, as well as the need for reinforcing the measures of salt restriction as prevention and control of high blood pressure, a very relevant risk factor associated with cognitive decline.
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